Overview

Pharmacokinetics Of Alprazolam Sublingual Tablet Versus Conventional Tablet

Status:
Completed
Trial end date:
2011-05-01
Target enrollment:
Participant gender:
Summary
To assess if the sublingual tablet will have similar pharmacokinetics as the conventional tablet of alprazolam.
Phase:
Phase 1
Details
Lead Sponsor:
Pfizer
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Treatments:
Alprazolam